1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Natural Killer Cell Therapeutics Market Size Growth Rate by Type: 2019 VS 2024 VS 2034
1.2.2 NK Cell Therapies
1.2.3 NK Cell Directed Antibodies
1.3 Market by Application
1.3.1 Global Natural Killer Cell Therapeutics Market Growth by Application: 2019 VS 2024 VS 2034
1.3.2 Research & Academic Institutes
1.3.3 Hospitals
1.3.4 Specialty Clinics
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Natural Killer Cell Therapeutics Market Perspective (2019-2034)
2.2 Global Natural Killer Cell Therapeutics Growth Trends by Region
2.2.1 Global Natural Killer Cell Therapeutics Market Size by Region: 2019 VS 2024 VS 2034
2.2.2 Natural Killer Cell Therapeutics Historic Market Size by Region (2019-2025)
2.2.3 Natural Killer Cell Therapeutics Forecasted Market Size by Region (2025-2034)
2.3 Natural Killer Cell Therapeutics Market Dynamics
2.3.1 Natural Killer Cell Therapeutics Industry Trends
2.3.2 Natural Killer Cell Therapeutics Market Drivers
2.3.3 Natural Killer Cell Therapeutics Market Challenges
2.3.4 Natural Killer Cell Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Natural Killer Cell Therapeutics Players by Revenue
3.1.1 Global Top Natural Killer Cell Therapeutics Players by Revenue (2019-2025)
3.1.2 Global Natural Killer Cell Therapeutics Revenue Market Share by Players (2019-2025)
3.2 Global Natural Killer Cell Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Natural Killer Cell Therapeutics Revenue
3.4 Global Natural Killer Cell Therapeutics Market Concentration Ratio
3.4.1 Global Natural Killer Cell Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Natural Killer Cell Therapeutics Revenue in 2024
3.5 Global Key Players of Natural Killer Cell Therapeutics Head office and Area Served
3.6 Global Key Players of Natural Killer Cell Therapeutics, Product and Application
3.7 Global Key Players of Natural Killer Cell Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Natural Killer Cell Therapeutics Breakdown Data by Type
4.1 Global Natural Killer Cell Therapeutics Historic Market Size by Type (2019-2025)
4.2 Global Natural Killer Cell Therapeutics Forecasted Market Size by Type (2025-2034)
5 Natural Killer Cell Therapeutics Breakdown Data by Application
5.1 Global Natural Killer Cell Therapeutics Historic Market Size by Application (2019-2025)
5.2 Global Natural Killer Cell Therapeutics Forecasted Market Size by Application (2025-2034)
6 North America
6.1 North America Natural Killer Cell Therapeutics Market Size (2019-2034)
6.2 North America Natural Killer Cell Therapeutics Market Growth Rate by Country: 2019 VS 2024 VS 2034
6.3 North America Natural Killer Cell Therapeutics Market Size by Country (2019-2025)
6.4 North America Natural Killer Cell Therapeutics Market Size by Country (2025-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Natural Killer Cell Therapeutics Market Size (2019-2034)
7.2 Europe Natural Killer Cell Therapeutics Market Growth Rate by Country: 2019 VS 2024 VS 2034
7.3 Europe Natural Killer Cell Therapeutics Market Size by Country (2019-2025)
7.4 Europe Natural Killer Cell Therapeutics Market Size by Country (2025-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Natural Killer Cell Therapeutics Market Size (2019-2034)
8.2 Asia-Pacific Natural Killer Cell Therapeutics Market Growth Rate by Country: 2019 VS 2024 VS 2034
8.3 Asia-Pacific Natural Killer Cell Therapeutics Market Size by Region (2019-2025)
8.4 Asia-Pacific Natural Killer Cell Therapeutics Market Size by Region (2025-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Natural Killer Cell Therapeutics Market Size (2019-2034)
9.2 Latin America Natural Killer Cell Therapeutics Market Growth Rate by Country: 2019 VS 2024 VS 2034
9.3 Latin America Natural Killer Cell Therapeutics Market Size by Country (2019-2025)
9.4 Latin America Natural Killer Cell Therapeutics Market Size by Country (2025-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Natural Killer Cell Therapeutics Market Size (2019-2034)
10.2 Middle East & Africa Natural Killer Cell Therapeutics Market Growth Rate by Country: 2019 VS 2024 VS 2034
10.3 Middle East & Africa Natural Killer Cell Therapeutics Market Size by Country (2019-2025)
10.4 Middle East & Africa Natural Killer Cell Therapeutics Market Size by Country (2025-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck KGaA
11.1.1 Merck KGaA Company Details
11.1.2 Merck KGaA Business Overview
11.1.3 Merck KGaA Natural Killer Cell Therapeutics Introduction
11.1.4 Merck KGaA Revenue in Natural Killer Cell Therapeutics Business (2019-2025)
11.1.5 Merck KGaA Recent Development
11.2 Bristol-Myers Squibb Company
11.2.1 Bristol-Myers Squibb Company Company Details
11.2.2 Bristol-Myers Squibb Company Business Overview
11.2.3 Bristol-Myers Squibb Company Natural Killer Cell Therapeutics Introduction
11.2.4 Bristol-Myers Squibb Company Revenue in Natural Killer Cell Therapeutics Business (2019-2025)
11.2.5 Bristol-Myers Squibb Company Recent Development
11.3 Glycostem
11.3.1 Glycostem Company Details
11.3.2 Glycostem Business Overview
11.3.3 Glycostem Natural Killer Cell Therapeutics Introduction
11.3.4 Glycostem Revenue in Natural Killer Cell Therapeutics Business (2019-2025)
11.3.5 Glycostem Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Details
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Natural Killer Cell Therapeutics Introduction
11.4.4 Sanofi Revenue in Natural Killer Cell Therapeutics Business (2019-2025)
11.4.5 Sanofi Recent Development
11.5 Cytovia Therapeutics
11.5.1 Cytovia Therapeutics Company Details
11.5.2 Cytovia Therapeutics Business Overview
11.5.3 Cytovia Therapeutics Natural Killer Cell Therapeutics Introduction
11.5.4 Cytovia Therapeutics Revenue in Natural Killer Cell Therapeutics Business (2019-2025)
11.5.5 Cytovia Therapeutics Recent Development
11.6 ImmunityBio, Inc.
11.6.1 ImmunityBio, Inc. Company Details
11.6.2 ImmunityBio, Inc. Business Overview
11.6.3 ImmunityBio, Inc. Natural Killer Cell Therapeutics Introduction
11.6.4 ImmunityBio, Inc. Revenue in Natural Killer Cell Therapeutics Business (2019-2025)
11.6.5 ImmunityBio, Inc. Recent Development
11.7 Biohaven Pharmaceuticals
11.7.1 Biohaven Pharmaceuticals Company Details
11.7.2 Biohaven Pharmaceuticals Business Overview
11.7.3 Biohaven Pharmaceuticals Natural Killer Cell Therapeutics Introduction
11.7.4 Biohaven Pharmaceuticals Revenue in Natural Killer Cell Therapeutics Business (2019-2025)
11.7.5 Biohaven Pharmaceuticals Recent Development
11.8 Fate Therapeutics
11.8.1 Fate Therapeutics Company Details
11.8.2 Fate Therapeutics Business Overview
11.8.3 Fate Therapeutics Natural Killer Cell Therapeutics Introduction
11.8.4 Fate Therapeutics Revenue in Natural Killer Cell Therapeutics Business (2019-2025)
11.8.5 Fate Therapeutics Recent Development
11.9 EMERcell
11.9.1 EMERcell Company Details
11.9.2 EMERcell Business Overview
11.9.3 EMERcell Natural Killer Cell Therapeutics Introduction
11.9.4 EMERcell Revenue in Natural Killer Cell Therapeutics Business (2019-2025)
11.9.5 EMERcell Recent Development
11.10 Phio Pharmaceuticals
11.10.1 Phio Pharmaceuticals Company Details
11.10.2 Phio Pharmaceuticals Business Overview
11.10.3 Phio Pharmaceuticals Natural Killer Cell Therapeutics Introduction
11.10.4 Phio Pharmaceuticals Revenue in Natural Killer Cell Therapeutics Business (2019-2025)
11.10.5 Phio Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
